ProSciento and OWL Metabolomics are partnering to find eligible participants for clinical trials for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Articles by Carolina Henriques
A new digital support platform, IO Loop, is helping patients stay connected online with doctors before, during, and after treatment.
The National Organization for Rare Disorders (NORD) gave its 2017 Industry Innovation Award to Intercept Pharmaceuticals for the company’s…
Durect has signed an agreement with Sandoz to develop and market Posimir (Saber-bupivacaine), an investigational localized pain reliever,…
A new online community, called Liver Line and sponsored by Galectin Therapeutics, offers the latest information on liver health and research…
A child exposed to a mother’s high-fat diet while in the womb and breastfeeding is at greater risk of developing…
Boston-based Albireo Pharma hosted an April 13 breakfast presentation in New York that featured an overview of the company’s clinical programs as…